You are here
- Home
- Total number of clinical trials
A double-blind, randomised, cross-over, placebo-controlled study of repeated oral doses of AZD3480 and a single dose of donepezil to evaluate the pharmacokinetic interaction between AZD3480 and donepezil in healthy extensive and poor metabolisers of CYP2D6
- Disease
- schizophrenia, Alzheimer's Disease
- Drug Name
- AZD3480
- Generic Name
- AZD3480
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Dec 8, 2008
- Study Name
- D3690C00005
- Study Id
- D3690C00005
- ClinicalTrials.gov ID
- NCT00713765
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
